Stay updated on Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedSite revision updated to v3.4.2; funding-status notice (v3.4.1) removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check21 days agoChange DetectedAdded a government funding lapse notice with links for status updates and updated the site revision to v3.4.1 (replacing the previous v3.4.0 revision).SummaryDifference0.5%

- Check28 days agoChange DetectedAdded a glossary toggle, new QC/FEAR Act notices, and updated the revision to v3.4.0. Removed the older QC label, older FEAR Act label, and the previous revision label v3.3.4.SummaryDifference0.2%

- Check42 days agoChange DetectedFooter revision updated from v3.3.3 to v3.3.4.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a dedicated Locations section with Connecticut as a study site, replacing the former Connecticut Locations entry.SummaryDifference0.2%

- Check85 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2, a minor maintenance/version change that does not affect trial content or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial page.